Tovet (emollient Formulation) Aerosol, Foam
Product Images NDC 43538-952
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tovet (emollient Formulation) (NDC 43538-952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medimetriks Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Tovet 02)
Figure B (Tovet 03)
Figure C (Tovet 04)
Figure D (Tovet 05)
Figure E (Tovet 06)
Principal Display Panel (100 g Canister Carton)
This is a description of a medication called Tovet; it is a foam that contains clobetasol propionate at a concentration of 0.05%. This medication is formulated for topical use only and is not to be used orally or intravaginally. Each gram of Tovet foam contains 0.5 mg clobetasol propionate, along with other ingredients such as purified water, glycerin, and potassium citrate. The medication is dispensed from a pressurized canister, and should be shaken before use. The medication is flammable and should be kept away from heat and sources of ignition.*
Principal Display Panel (Kit Carton)
This is a description for Tovet Foam, which contains 0.05% clobetasol propionate, and is for topical use only. The product is available in a 25g canister with serialization code, lot number, and expiration date. The foam is not for ophthalmic, oral, or intravaginal use. The package is only available with an Rx.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.